Life Science Today 037 – (Bonus) Interview with Dr. Mitrani, CSO at Organicell
Originally Published as The Niche Podcast
I sit down with Dr. Mitrani, the Chief Scientific Officer for Organicell, a clinical stage biopharma company focused on regenerative medicine. Their leading product, Zofin is currently in early clinical trials for the treatment of COVID19. Eventually it may be a therapeutic for long haulers.
TRANSCRIPT UNAVAILABLE
Key Talking Points
2:43 - Dr. Mitrani’s Journey to regenerative medicine
5:30 - From stem cells to nano medicine
8:12 - What is Zofin and how might it work?
9:46 - Pivoting into COVID19
11:42 - Following the science from stem cells to nano infusions
14:21 - Doing science is hard but we follow the data
19:59 - How following scientific data for years prepares you to pivot in response to crisis
25:40 - What trends have stood the test of time?
30:27 - How novel therapeutic spaces require novel approaches to product validation
34:11 - The work that is being done for COVID19 long-haulers
Sponsors
https://www.thescopemethod.com
Story References
https://organicell.com/
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson